No Arabic abstract
Currently, Chronic Kidney Disease (CKD) is experiencing a globally increasing incidence and high cost to health systems. A delayed recognition implies premature mortality due to progressive loss of kidney function. The employment of data mining to discover subtle patterns in CKD indicators would contribute achieving early diagnosis. This work presents the development and evaluation of an explainable prediction model that would support clinicians in the early diagnosis of CKD patients. The model development is based on a data management pipeline that detects the best combination of ensemble trees algorithms and features selected concerning classification performance. The results obtained through the pipeline equals the performance of the best CKD prediction models identified in the literature. Furthermore, the main contribution of the paper involves an explainability-driven approach that allows selecting the best prediction model maintaining a balance between accuracy and explainability. Therefore, the most balanced explainable prediction model of CKD implements an XGBoost classifier over a group of 4 features (packed cell value, specific gravity, albumin, and hypertension), achieving an accuracy of 98.9% and 97.5% with cross-validation technique and with new unseen data respectively. In addition, by analysing the models explainability by means of different post-hoc techniques, the packed cell value and the specific gravity are determined as the most relevant features that influence the prediction results of the model. This small number of feature selected results in a reduced cost of the early diagnosis of CKD implying a promising solution for developing countries.
Cardiovascular disease, especially heart failure is one of the major health hazard issues of our time and is a leading cause of death worldwide. Advancement in data mining techniques using machine learning (ML) models is paving promising prediction approaches. Data mining is the process of converting massive volumes of raw data created by the healthcare institutions into meaningful information that can aid in making predictions and crucial decisions. Collecting various follow-up data from patients who have had heart failures, analyzing those data, and utilizing several ML models to predict the survival possibility of cardiovascular patients is the key aim of this study. Due to the imbalance of the classes in the dataset, Synthetic Minority Oversampling Technique (SMOTE) has been implemented. Two unsupervised models (K-Means and Fuzzy C-Means clustering) and three supervised classifiers (Random Forest, XGBoost and Decision Tree) have been used in our study. After thorough investigation, our results demonstrate a superior performance of the supervised ML algorithms over unsupervised models. Moreover, we designed and propose a supervised stacked ensemble learning model that can achieve an accuracy, precision, recall and F1 score of 99.98%. Our study shows that only certain attributes collected from the patients are imperative to successfully predict the surviving possibility post heart failure, using supervised ML algorithms.
Predicting the incidence of complex chronic conditions such as heart failure is challenging. Deep learning models applied to rich electronic health records may improve prediction but remain unexplainable hampering their wider use in medical practice. We developed a novel Transformer deep-learning model for more accurate and yet explainable prediction of incident heart failure involving 100,071 patients from longitudinal linked electronic health records across the UK. On internal 5-fold cross validation and held-out external validation, our model achieved 0.93 and 0.93 area under the receiver operator curve and 0.69 and 0.70 area under the precision-recall curve, respectively and outperformed existing deep learning models. Predictor groups included all community and hospital diagnoses and medications contextualised within the age and calendar year for each patients clinical encounter. The importance of contextualised medical information was revealed in a number of sensitivity analyses, and our perturbation method provided a way of identifying factors contributing to risk. Many of the identified risk factors were consistent with existing knowledge from clinical and epidemiological research but several new associations were revealed which had not been considered in expert-driven risk prediction models.
Objective: To combine medical knowledge and medical data to interpretably predict the risk of disease. Methods: We formulated the disease prediction task as a random walk along a knowledge graph (KG). Specifically, we build a KG to record relationships between diseases and risk factors according to validated medical knowledge. Then, a mathematical object walks along the KG. It starts walking at a patient entity, which connects the KG based on the patient current diseases or risk factors and stops at a disease entity, which represents the predicted disease. The trajectory generated by the object represents an interpretable disease progression path of the given patient. The dynamics of the object are controlled by a policy-based reinforcement learning (RL) module, which is trained by electronic health records (EHRs). Experiments: We utilized two real-world EHR datasets to evaluate the performance of our model. In the disease prediction task, our model achieves 0.743 and 0.639 in terms of macro area under the curve (AUC) in predicting 53 circulation system diseases in the two datasets, respectively. This performance is comparable to the commonly used machine learning (ML) models in medical research. In qualitative analysis, our clinical collaborator reviewed the disease progression paths generated by our model and advocated their interpretability and reliability. Conclusion: Experimental results validate the proposed model in interpretably evaluating and optimizing disease prediction. Significance: Our work contributes to leveraging the potential of medical knowledge and medical data jointly for interpretable prediction tasks.
With the overwhelming popularity of Knowledge Graphs (KGs), researchers have poured attention to link prediction to fill in missing facts for a long time. However, they mainly focus on link prediction on binary relational data, where facts are usually represented as triples in the form of (head entity, relation, tail entity). In practice, n-ary relational facts are also ubiquitous. When encountering such facts, existing studies usually decompose them into triples by introducing a multitude of auxiliary virtual entities and additional triples. These
Cardiovascular diseases and their associated disorder of heart failure are one of the major death causes globally, being a priority for doctors to detect and predict its onset and medical consequences. Artificial Intelligence (AI) allows doctors to discover clinical indicators and enhance their diagnosis and treatments. Specifically, explainable AI offers tools to improve the clinical prediction models that experience poor interpretability of their results. This work presents an explainability analysis and evaluation of a prediction model for heart failure survival by using a dataset that comprises 299 patients who suffered heart failure. The model employs a data workflow pipeline able to select the best ensemble tree algorithm as well as the best feature selection technique. Moreover, different post-hoc techniques have been used for the explainability analysis of the model. The papers main contribution is an explainability-driven approach to select the best prediction model for HF survival based on an accuracy-explainability balance. Therefore, the most balanced explainable prediction model implements an Extra Trees classifier over 5 selected features (follow-up time, serum creatinine, ejection fraction, age and diabetes) out of 12, achieving a balanced-accuracy of 85.1% and 79.5% with cross-validation and new unseen data respectively. The follow-up time is the most influencing feature followed by serum-creatinine and ejection-fraction. The explainable prediction model for HF survival presented in this paper would improve a further adoption of clinical prediction models by providing doctors with intuitions to better understand the reasoning of, usually, black-box AI clinical solutions, and make more reasonable and data-driven decisions.